Casdin Capital’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-750,000
| Closed | -$9.47M | – | 46 |
|
|
2020
Q2 | $9.47M | Sell |
750,000
-345,075
| -32% | -$4.35M | 0.56% | 36 |
|
|
2020
Q1 | $10M | Hold |
1,095,075
| – | – | 1.06% | 27 |
|
|
2019
Q4 | $15.3M | Sell |
1,095,075
-33,000
| -3% | -$460K | 1.4% | 24 |
|
|
2019
Q3 | $19.4M | Hold |
1,128,075
| – | – | 2.01% | 17 |
|
|
2019
Q2 | $30.7M | Hold |
1,128,075
| – | – | 2.87% | 14 |
|
|
2019
Q1 | $21.6M | Hold |
1,128,075
| – | – | 2.37% | 16 |
|
|
2018
Q4 | $10.6M | Sell |
1,128,075
-6,925
| -0.6% | -$65.1K | 1.81% | 23 |
|
|
2018
Q3 | $21.5M | Hold |
1,135,000
| – | – | 2.61% | 18 |
|
|
2018
Q2 | $22.2M | Hold |
1,135,000
| – | – | 3.1% | 13 |
|
|
2018
Q1 | $21.3M | Hold |
1,135,000
| – | – | 3.75% | 14 |
|
|
2017
Q4 | $18.8M | Buy |
1,135,000
+320,000
| +39% | +$5.31M | 4.59% | 10 |
|
|
2017
Q3 | $16.8M | Buy |
815,000
+75,000
| +10% | +$1.54M | 4.74% | 11 |
|
|
2017
Q2 | $6.63M | Buy |
740,000
+240,000
| +48% | +$2.15M | 2.45% | 17 |
|
|
2017
Q1 | $6.62M | Buy |
500,000
+115,000
| +30% | +$1.52M | 3.91% | 9 |
|
|
2016
Q4 | $4.91M | Buy |
385,000
+108,500
| +39% | +$1.38M | 4.05% | 10 |
|
|
2016
Q3 | $3.32M | Sell |
276,500
-46,000
| -14% | -$552K | 2.69% | 13 |
|
|
2016
Q2 | $3.54M | Sell |
322,500
-16,862
| -5% | -$185K | 3.53% | 13 |
|
|
2016
Q1 | $2.96M | Buy |
339,362
+102,500
| +43% | +$895K | 3.4% | 13 |
|
|
2015
Q4 | $5.19M | Buy |
+236,862
| New | +$5.19M | 4.58% | 13 |
|